These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11208488)

  • 1. Stoppage of blood flow in 3-methylcholanthrene-induced autochthonous primary tumor due to a novel combretastatin A-4 derivative, AC7700, and its antitumor effect.
    Hori K; Saito S; Sato Y; Kubota K
    Med Sci Monit; 2001; 7(1):26-33. PubMed ID: 11208488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.
    Hori K; Saito S; Nihei Y; Suzuki M; Sato Y
    Jpn J Cancer Res; 1999 Sep; 90(9):1026-38. PubMed ID: 10551334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.
    Hori K; Saito S; Kubota K
    Br J Cancer; 2002 May; 86(10):1604-14. PubMed ID: 12085211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic strategy: irreversible tumor blood flow stasis induced by the combretastatin A-4 derivative AVE8062 (AC7700).
    Hori K
    Chemotherapy; 2005 Oct; 51(6):357-60. PubMed ID: 16227690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.
    Hori K; Saito S
    Br J Cancer; 2003 Oct; 89(7):1334-44. PubMed ID: 14520469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700).
    Hori K; Saito S
    Br J Cancer; 2004 Jan; 90(2):549-53. PubMed ID: 14735207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor blood flow interruption after radiotherapy strongly inhibits tumor regrowth.
    Hori K; Furumoto S; Kubota K
    Cancer Sci; 2008 Jul; 99(7):1485-91. PubMed ID: 18452559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs. implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062).
    Hori K; Saito S; Sato Y; Akita H; Kawaguchi T; Sugiyama K; Sato H
    Eur J Cancer; 2003 Sep; 39(13):1957-66. PubMed ID: 12932676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
    Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
    Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.
    Nihei Y; Suga Y; Morinaga Y; Ohishi K; Okano A; Ohsumi K; Hatanaka T; Nakagawa R; Tsuji T; Akiyama Y; Saito S; Hori K; Sato Y; Tsuruo T
    Jpn J Cancer Res; 1999 Sep; 90(9):1016-25. PubMed ID: 10551333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and antivascular effects of AC-7700, a combretastatin A-4 derivative, against rat liver cancer.
    Ohno T; Kawano K; Sasaki A; Aramaki M; Tahara K; Etoh T; Kitano S
    Int J Clin Oncol; 2002 Jun; 7(3):171-6. PubMed ID: 12109519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inflammatory responses in rats and mice with autochthonous and transplanted tumors induced by 3-methylcholanthrene.
    Normann SJ; Schardt MC; Sorkin E
    J Natl Cancer Inst; 1984 Jan; 72(1):175-84. PubMed ID: 6229667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.
    Tozer GM; Prise VE; Wilson J; Locke RJ; Vojnovic B; Stratford MR; Dennis MF; Chaplin DJ
    Cancer Res; 1999 Apr; 59(7):1626-34. PubMed ID: 10197639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunological studies in rats following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors.
    Hayakawa K; Yamashita T; Suzuki K; Tomita K; Hosokawa M; Kodama T; Kobayashi H
    Gan; 1982 Jun; 73(3):462-9. PubMed ID: 7129011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride.
    Hori K; Saito S; Takahashi H; Sato H; Maeda H; Sato Y
    Jpn J Cancer Res; 2000 Feb; 91(2):261-9. PubMed ID: 10761715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of spontaneous metastases from autochthonous 3-methylcholanthrene-induced tumors.
    Bottazzi B; Mantovani A; Taraboletti G; Giavazzi R
    Invasion Metastasis; 1986; 6(1):44-57. PubMed ID: 3941028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental radiation therapy and apparent radioresistance of autochthonous tumors subcutaneously induced with 3-methylcholanthrene in mice.
    Tanooka H; Hoshino H; Tanaka K; Nagase M
    Cancer Res; 1980 Jul; 40(7):2547-51. PubMed ID: 7388810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of tumor vessels: selective increase in tumor blood flow.
    Suzuki M; Hori K; Saito S; Tanda S; Abe I; Sato H; Sato H
    Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):37-45. PubMed ID: 2640066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.